Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crookes Laboratories was a prominent British pharmaceutical company founded in 1912, originally established to commercialize the scientific work of chemist Sir William Crookes. The company gained early distinction for its pioneering development of "Collosols," which were stable colloidal medicinal preparations of metals and other substances. Over the mid-20th century, it transitioned into a major manufacturer of consumer healthcare products, becoming widely known for household brands such as the skin care lotion Lacto-Calamine and the decongestant Karvol. The company underwent several ownership changes, being acquired by Guinness in 1960 and subsequently by The Boots Company in 1971. Under Boots, it operated as Crookes Healthcare before its brands were eventually integrated into larger global entities like Reckitt Benckiser.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crookes Laboratories.